Tech stocks had come under selling pressure temporarily because of the prevailing negative sentiment in view of anti trust move against Google. However, the favourable court ruling has been able to ward off this.
Backed by good business models, these are expected to face near term tail winds also, cementing their long term growth potential.
Pro Medicus Limited (ASX: PME)
is a top player in enterprise imaging and radiology systems with its Visage RIS and Visage 7 platforms. The company is based in Melbourne but also has offices in San Diego and Berlin. In FY25 it posted record sales of A$213.0 million which is 31.9% higher than FY24. NPAT came at A$115.2 million, up 39.2% year on year, while underlying EBIT was A$157.7 million giving margins of around 74%. PME is still debt free and holds A$210.7 million in cash and investments which shows how strong its balance sheet is. Shareholders were given a final fully franked dividend of $0.30 which is 37.5% higher than last year. The year was strong with 7 new contracts worth A$520 million and 2 big renewals worth A$130 million plus upgrades of A$39 million. It also finished 7 cloud based implementations. On top of that PME signed a research collab with UCSF and pushed forward in cardiology, digital pathology and AI which will help it keep growing into FY26 and the future.
works in providing online business solutions for small businesses and their advisors.It posted strong results for FY25 with operating revenue going up 23% year on year to NZ$2.10 billion. This growth came from solid performance in its major markets. Adjusted EBITDA stood at NZ$641 million, rising 22% from last year and free cash flow margin came at 24% showing a balance between revenue growth and profits. Subscriber base grew 10% on underlying basis to 4.41 million and average revenue per user went up 11% to NZ$45.08.For FY26 the company expects operating expenses to stay close to 71.5% of revenue with more spending in first half because of one time remuneration impacts and seasonal investments. The purchase of Melio, a bill pay platform in the US, is expected to boost growth, almost triple its US revenue and give a clear way to more than double total group revenue by FY28.
is a company that runs a tech platform to help find people, pets and even things that are important for families. It works in the space of family, safety and technology to keep everyone connected. In Q2 2025 it showed strong results with revenue of US$115.4 million compared to US$84.9 million in Q2 2024, this was mainly because of more subscriptions and expansion in other countries. Subscription revenue touched US$88.6 million, hardware brought in US$12.3 million, while other revenue more than doubled to US$14.5 million.The company also posted a net income of US$7.0 million for the quarter compared to a loss of US$11.0 million last year in the same period and EPS was US$0.08. For the first half of FY25 total revenue was US$219.0 million and net profit stood at US$11.4 million. The balance sheet looks better with US$432.7 million in cash and total assets of US$753.6 million.The company is aiming for more growth ahead by increasing subscriptions, expanding more global markets and adding new services to boost recurring income.
(Source: Company Announcements)
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
